Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Mtech Access certified as a NICE META tool facilitating organisation

November 21, 2023 | META Tool, Medtech, NICE, diagnostics, digital health 

Mtech Access are now a certified NICE META Tool facilitating organisation, with three experts having passed the NICE assessment

In summary:

  • Mtech Access are now a certified NICE Medtech Early Technical Assessment (META) Tool facilitating organisation, ready to support Medtech and digital health companies with the META Tool process, and their wider evidence and launch strategies
  • The META Tool was developed by NICE in collaboration with Health Innovation Manchester to help Medtech companies identify gaps in their product development and evidence generation plans
  • Samantha Gillard (Director – HTA), Persefoni Ioannou (Consultant – HTA), and Calum Jones (Senior Consultant – Health Economics) all recently passed the NICE META Tool assessment
  • The team are hosting a free webinar on Friday 12th January at 2.00pm to explore some of the evidence challenges facing Medtech and Digital Health innovators

Mtech Access are delighted to announce that they are now a certified NICE Medtech Early Technical Assessment (META) Tool facilitating organisation. Mtech Access’ experts, Samantha Gillard (Director – HTA), Persefoni Ioannou (Consultant – HTA), and Calum Jones (Senior Consultant – Health Economics) all recently passed the NICE META Tool assessment. As accredited facilitators, the team will support Medtech and Digital Health innovators through the META Tool process and beyond. The Mtech Access Team are one of a small number of accredited organisations able to support Medtech innovators throughout commercialisation and launch.

The META Tool was developed by NICE in collaboration with Health Innovation Manchester to help Medtech companies identify gaps in their product development and evidence generation plans. The META tool process helps Medtech companies and product developers understand the evidence requirements for NICE or other payers, and the impact of the differences between regulatory and payer frameworks. It can be used at any stage of product development to explore evidence requirements.

“We are really excited to bring this new service to Medtech, Diagnostic, and Digital Health innovators. Developing the right evidence base that resonates with payers and meets the requirements of assessment bodies like NICE is increasingly important for successful launch and commercialisation. There are so many new technologies with great potential to make a real difference in healthcare settings – it’s fantastic to offer a new service to help make this happen.”
– Samantha Gillard (Director – HTA, Mtech Access).

As a certified NICE META tool facilitating organisation, via the META Tool assessment, Mtech Access will help Medtech and Digital Health companies to identify gaps in the product’s evidence package, relevant to HTA and healthcare provider evidence requirements.

In addition to the assessment itself, Mtech Access offer a full suite of HTA and medical technology commercialisation services, including strategy through to evidence generation, economic model development, submission writing, and post-submission support. Learn more about the Mtech Access META Tool service and supporting solutions at: https://mtechaccess.co.uk/meta-tool/

About Mtech Access:

At Mtech Access, we provide strategies and solutions to help Medtech companies, as well as the wider Pharmaceutical and life sciences sector, bring interventions to market, providing more patient choice and meeting the needs of the healthcare environment. Our consultants and technical experts support Global teams and affiliates throughout the product lifecycle, from evidence generation and strategy to communication of value. The HTA specialists have collectively supported over 170 UK and Ireland HTA submissions throughout their careers.

https://mtechaccess.co.uk/

This content was provided by Petauri Evidence